Delaware Governor John Carney has signed three pieces of legislation into law aimed at curbing rising healthcare costs, increasing transparency for patients, and regulating private equity investment in medical facilities. The new laws, enacted in mid-July 2024, represent a significant shift in state-level oversight of hospital pricing and the growing influence of investment firms in the healthcare sector, according to official records from the Delaware General Assembly.
The legislative package includes House Bill 350, which establishes a hospital cost review board, Senate Bill 200, focused on private equity transparency, and House Bill 349, which enhances financial assistance protections for low-income residents. These measures follow months of debate regarding the affordability of care in the state and the impact of consolidation on patient services.
Oversight of Hospital Pricing and Cost Containment
House Bill 350 creates a Hospital Cost Review Board tasked with monitoring hospital financial performance and setting annual growth targets for healthcare spending. Under the provisions of HB 350, hospitals that exceed these state-mandated growth benchmarks may be required to submit performance improvement plans. The intent is to slow the rate of increase in hospital-based care costs, which have outpaced inflation in several regions over the past decade.
The board will be composed of appointees representing healthcare providers, consumer advocates, and state officials. By establishing formal review processes, the state aims to identify systemic inefficiencies and prevent excessive billing practices. This mechanism is similar to cost-containment models implemented in other states, such as Massachusetts, which have sought to tie hospital revenue growth to broader economic indicators.
Private Equity and Facility Acquisitions
Senate Bill 200 addresses concerns regarding the impact of private equity firms purchasing medical practices and hospitals. The legislation mandates that any entity seeking to acquire a controlling interest in a Delaware healthcare facility must provide the state with detailed disclosure regarding the transaction and its potential impact on patient care, staffing levels, and service availability, as detailed in the official bill summary published by the Delaware General Assembly.
Regulators now have the authority to block or place conditions on acquisitions if they determine the transaction could harm public health or significantly reduce access to essential services. This move comes amid national scrutiny of private equity’s role in healthcare, with critics arguing that profit-driven management can lead to cost-cutting measures that compromise clinical outcomes. Supporters of the bill maintain that transparency is necessary to ensure that corporate ownership does not undermine the mission of community healthcare providers.
Strengthening Patient Financial Assistance
House Bill 349 expands the requirements for hospitals to provide financial assistance, often referred to as charity care, to low-income patients. The law updates the criteria for eligibility, ensuring that a broader segment of the population can qualify for discounted or free medical care. As noted in the final text of HB 349, hospitals are now required to provide clearer notices to patients regarding their rights to request financial aid before aggressive collection efforts begin.
This law aims to reduce the burden of medical debt, which is a leading cause of personal bankruptcy in the United States. By standardizing the application process across the state, Delaware officials aim to ensure that financial assistance is not a “hidden” benefit but a accessible pathway for those struggling to pay for emergency or elective procedures.
Impact on the Healthcare Landscape
The cumulative effect of these three bills is a more regulated environment for healthcare institutions in Delaware. Hospital administrators have expressed concerns regarding the administrative burden of the new reporting requirements, while consumer groups have largely lauded the measures as a necessary step toward protecting patients. The state’s Department of Health and Social Services is expected to begin the rule-making process for these laws in the coming months.
Stakeholders are now looking toward the implementation phase, which will determine the rigor of the oversight board and the frequency with which the state intervenes in private equity transactions. The next scheduled update from the Delaware Department of Health and Social Services regarding the implementation timeline is expected in the fall of 2024. Residents seeking information on how these changes may affect their access to financial assistance programs should monitor the official Delaware Department of Health and Social Services website for upcoming guidance and public hearing notices.